The "OPTN Gene Glaucoma Open Angle Type 1E Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the OPTN gene that are associated with open-angle glaucoma type 1E. Open-angle glaucoma is the most common form of glaucoma, characterized by a gradual loss of vision due to damage to the optic nerve, often without early symptoms. The OPTN gene plays a crucial role in the regulation of intraocular pressure and the normal functioning of the optic nerve. Mutations in this gene can lead to impaired ocular fluid drainage, increased eye pressure, and ultimately, optic nerve damage.
This genetic test is a powerful tool for early detection and risk assessment, allowing individuals to understand their susceptibility to developing this form of glaucoma. Early identification of genetic predispositions can lead to proactive monitoring and timely interventions, potentially preserving vision. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific genetic variations in the OPTN gene.
DNA Labs UAE offers this test at a cost of 4400 AED. By providing this service, DNA Labs UAE enables individuals and families to make informed decisions about their eye health and take preventative measures against one of the leading causes of blindness worldwide. It is especially beneficial for those with a family history of glaucoma, as it offers a deeper insight into their genetic risk factors.
The ASB10 Gene Glaucoma Open Angle Type 1F Genetic Test is a specialized diagnostic tool designed to identify mutations in the ASB10 gene, which are implicated in the development of open-angle glaucoma type 1F. Open-angle glaucoma is the most common form of glaucoma, characterized by the gradual loss of vision due to damage to the optic nerve, often without early symptoms. The ASB10 gene plays a crucial role in eye health, and mutations in this gene can significantly increase the risk of developing this type of glaucoma.
This genetic test is particularly important for individuals with a family history of glaucoma or those who are at an increased risk of developing the condition. Early identification of genetic predispositions allows for timely intervention and management strategies to prevent or slow down the progression of glaucoma, preserving vision.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the ASB10 Gene Glaucoma Open Angle Type 1F Genetic Test is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the ASB10 gene. Results from this test can provide valuable information for personalized treatment plans and preventive measures for individuals at risk of developing open-angle glaucoma type 1F.
The NTF4 Gene Glaucoma Open Angle Type 1F Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the NTF4 gene, which have been associated with the development of open-angle glaucoma, specifically type 1F. Open-angle glaucoma is the most common form of glaucoma, characterized by the gradual loss of vision due to damage to the optic nerve, often without early symptoms. Mutations in the NTF4 gene can lead to reduced neurotrophin-4 protein levels, which is crucial for the survival of retinal ganglion cells. Identifying mutations in this gene can provide crucial information for the early detection and management of glaucoma, potentially preserving vision.
The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations in the NTF4 gene. Results from this test can help healthcare providers develop a more personalized treatment plan for patients at risk of or diagnosed with open-angle glaucoma, focusing on early intervention and tailored management strategies to slow the progression of the disease.
The WDR36 Gene Glaucoma Open Angle Type 1G Genetic Test is a specialized diagnostic assessment offered at DNA Labs UAE, designed to detect mutations in the WDR36 gene, which have been associated with open-angle glaucoma, the most common form of glaucoma. Open-angle glaucoma is characterized by the gradual loss of vision due to damage to the optic nerve, often without early symptoms, making genetic testing a valuable tool for early detection and management.
The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for specific genetic variations in the WDR36 gene that are known to increase the risk of developing open-angle glaucoma. Identifying individuals at risk allows for early intervention, potentially slowing the progression of the disease and preserving vision. DNA Labs UAE provides this testing service with a focus on accuracy, confidentiality, and support, offering a crucial resource for those with a family history of glaucoma or individuals experiencing related symptoms.
The CYP1B1 Gene Glaucoma Primary Type 3A Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the CYP1B1 gene that are associated with Primary Congenital Glaucoma (PCG), specifically type 3A. This form of glaucoma is a severe eye condition that typically presents itself in infancy or early childhood, leading to increased intraocular pressure, optic nerve damage, and potentially, loss of vision if left untreated. The CYP1B1 gene plays a critical role in the development of the eye's drainage system; mutations in this gene can disrupt this system, leading to the accumulation of eye fluid and increased pressure.
The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of genetic alterations in the CYP1B1 gene. Identifying these mutations can provide valuable information for the early diagnosis and management of glaucoma, allowing for timely intervention and a better prognosis for affected individuals. Additionally, this test can be useful for families with a history of Primary Congenital Glaucoma, offering them an opportunity for genetic counseling and informed decision-making regarding family planning. DNA Labs UAE utilizes advanced genetic testing technologies to ensure accurate and reliable results, contributing to the effective detection and management of glaucoma in susceptible individuals.
The "LTBP2 Gene Glaucoma Primary Type 3D Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the LTBP2 gene, which have been linked to the development of primary congenital glaucoma (PCG) type 3D. This condition is a rare form of glaucoma that typically presents itself at birth or during the first few years of life, leading to increased intraocular pressure, optic nerve damage, and potentially severe vision loss if not diagnosed and treated early.
The test, priced at 4400 AED, utilizes advanced genetic sequencing techniques to analyze the LTBP2 gene for specific genetic variations known to contribute to this form of glaucoma. By identifying these mutations, healthcare providers can confirm a diagnosis of primary congenital glaucoma type 3D, enabling them to tailor treatment strategies more effectively and provide targeted interventions. Additionally, this test can offer valuable information for family planning and genetic counseling for families affected by this condition.
Performed at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, the LTBP2 Gene Glaucoma Primary Type 3D Genetic Test represents a crucial tool in the early detection and management of this serious eye condition, ultimately helping to preserve vision and improve the quality of life for those affected.
The "OAT Gene Gyrate Atrophy of Choroid and Retina with or without Ornithinemia Genetic Test" is a specialized diagnostic procedure aimed at detecting mutations in the OAT gene, which are responsible for gyrate atrophy of the choroid and retina. This rare genetic disorder is characterized by progressive vision loss, typically beginning in childhood or adolescence. The condition may also be associated with ornithinemia, an abnormal accumulation of ornithine in the blood due to the body's inability to properly metabolize this amino acid.
Performed at DNA Labs UAE, this genetic test plays a crucial role in the early identification and management of the disorder. By analyzing a sample of the patient's DNA, the test can confirm the presence of specific mutations in the OAT gene, thereby aiding in the diagnosis of gyrate atrophy and guiding treatment decisions. The cost of the test is 4400 AED, reflecting the specialized technology and expertise required to accurately identify the genetic mutations associated with this condition.
Early diagnosis through this genetic test is essential for managing symptoms, slowing the progression of vision loss, and improving the quality of life for affected individuals. It also provides valuable information for family planning and the assessment of risk in future offspring.
The RB1 Gene Hereditary Retinoblastoma Genetic Test is a crucial diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RB1 gene, which are strongly associated with hereditary retinoblastoma. Retinoblastoma is a rare form of eye cancer that predominantly affects young children and can be inherited. Early detection through this genetic testing can be life-saving and significantly influence the management and treatment options for affected individuals and their families.
The test, priced at 4400 AED, involves analyzing the patient's DNA to look for abnormalities in the RB1 gene, which plays a critical role in cell cycle regulation and tumor suppression. By identifying specific mutations in this gene, healthcare providers can assess an individual's risk for developing retinoblastoma and implement appropriate surveillance and preventive measures.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the RB1 Gene Hereditary Retinoblastoma Genetic Test is performed under strict quality control measures, ensuring accurate and reliable results. The test not only aids in the early detection of retinoblastoma but also provides valuable information for family planning and the assessment of risk in siblings and future generations.
The HPS4 gene Hermansky-Pudlak syndrome type 4 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the HPS4 gene, which are responsible for causing Hermansky-Pudlak syndrome (HPS) type 4. This rare genetic disorder is characterized by a lack of pigmentation (albinism), bleeding disorders, and lung and bowel diseases. The test is crucial for early diagnosis, allowing for appropriate management and treatment of the condition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the HPS4 gene. The results can help in confirming the diagnosis, understanding the severity of the disorder, and informing patients and families about potential complications and the risk of passing the condition to future generations.
The cost of the HPS4 gene Hermansky-Pudlak syndrome type 4 genetic test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the specialized technology and expertise required to interpret the results accurately, the price reflects the comprehensive analysis and detailed report provided to patients or their healthcare providers. This test is an essential tool for individuals with a family history of HPS or related symptoms, guiding their healthcare decisions and improving their quality of life through tailored medical care.
The HPS1 gene Hermansky-Pudlak syndrome type 1 genetic test is a specialized diagnostic tool used to identify mutations in the HPS1 gene, which are indicative of Hermansky-Pudlak syndrome type 1 (HPS1). HPS1 is a rare genetic disorder characterized by a lack of pigmentation (albinism), bleeding disorders, and lung and bowel diseases. It is caused by mutations in the HPS1 gene, which plays a crucial role in the formation and function of lysosomes and related organelles in cells.
This genetic test is vital for the early diagnosis and management of HPS1, allowing for appropriate interventions and treatments to mitigate the symptoms and improve the quality of life for affected individuals. Early diagnosis can also provide valuable information for family planning and genetic counseling for families with a history of the disorder.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure reliable and precise testing outcomes, making it a trusted choice for genetic diagnostics in the region.
